F049 AI in healthcare 3/6: Impacts in diabetes (Tadej Battelino)
In 2016 FDA approved the so-called artificial pancreas – Medtronic’s MiniMed 670G system (Medtronic) a hybrid closed-looped system for glucose measurement and insulin delivery. A lot of companies are developing AI supported decision support systems for doctors and patients. This episode dives in the complexity of diabetes, how it is treated, what role does glucose have on health and how is technology improving the lives of patients with diabetes. Speaker: prof. Dr. Tadej Battelino, the head of Department of Pediatric endocrinology, diabetes and metabolism at the UMC – University Children’s Hospital Ljubljana, Slovenia. Prof. Battelino is among other things co-organizer of Advanced Technologies and Treatment of Diabetes Conference – that provides a world-class platform for clinicians and scientists to present, discuss and exchange insights on the most rapidly evolving area of diabetes technology and treatments. He is also Chiel Clinical at Dreamed Diabetes – Israeli based developer of personalized diabetes management solutions. DreamedDiabetes Advisor Pro decision support system received an FDA approval in 2018.
